Medicine & Life Sciences
nintedanib
100%
Renal Cell Carcinoma
34%
Vascular Endothelial Growth Factor A
23%
Angiogenesis Inhibitors
21%
Neoplasms
20%
Non-Small Cell Lung Carcinoma
16%
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
14%
pazopanib
13%
Sunitinib
11%
Breast Neoplasms
11%
Medullary Thyroid cancer
11%
Sorafenib
11%
Fibroblast Growth Factors
10%
Platelet-Derived Growth Factor
10%
Therapeutics
10%
Docetaxel
9%
Bevacizumab
9%
Ovarian Neoplasms
8%
Stomach Neoplasms
7%
Hepatocellular Carcinoma
7%
Colorectal Neoplasms
7%
Prostatic Neoplasms
7%
Monoclonal Antibodies
6%
Neoplasm Metastasis
5%
Drug Therapy
5%
Safety
5%
Growth
4%